CEO's On the Move

Taro Pharmaceutical Industries Ltd. Appoints Abhay Gandhi as Interim Ceo, Effective January 1, 2017
12/1/2016
Taro Pharmaceutical Industries Ltd. (TARO:US:NYSE) Taro Pharmaceutical Industries Ltd. announced that its Board of Directors has appointed Mr. Abhay Gandhi to the position of Interim Chief Executive Officer, effective January 1, 2017. As previously announced, the Interim CEO will serve in this role during the period from Mr. Kal Sundaram’s departure ...

Upcoming Board Meetings

Colgate-Palmolive (India) Limited
(CLGT:IN:National Stock Exchange of India)
December 5, 2016
Colgate-Palmolive (India) Limited, Board Meeting, Dec 05, 2016. Agenda: To consider and declare the second interim dividend for the financial year 2016-2017.
Announced 11/16/16
Colgate-Palmolive (India) Limited Key Board Members
Issam Bachaalani
Managing Director and Director
Pradyot Ghosh
Deputy Chairman

Executive Changes

Shri Aster Silicates Ltd Appoints Lekha Manibhai Buch as an Additional Director
12/4/16
Shri Aster Silicates Ltd. announced that Ms. Lekha Manibhai Buch has been appointed as an Additional director of the company with effect from December 03, 2016.
Maris Spinners Ltd Announces Change of Board of Directors
12/3/16
Maris Spinners Ltd. announced the change in Board of Directors of the company at its meeting held on October 31, 2016. The company announced the resignation of Mr. M Rengaswamy, Director, has been considered with effect from Nov. 01, 2016 and Mr. A Hari Govind has been appointed as a Director with effect from Nov. 01, 2016.
Tree House Education & Accessories Ltd. Announces Management Changes
12/3/16
Tree House Education & Accessories Ltd. announced at the board of directors meeting held on December 2, 2016 has approved the appointment of Mr. Raja Kumar as an additional director in the category of Independent Non-Executive Director of the company, effective December 02, 2016. The change in designation of Mr. Rajesh Bhatia from Managing Director to Whole Time Director of the company with effect from December 2, 2016.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Top Compensated Executives at TARO:US

Name/TitleAnnual Compensation
Kalyanasundaram Subramanian$800.0K
Chief Executive Officer and Director
Michael Perfetto$555.4K
Group Vice President and Chief Commercial Officer of the Generic Rx Business, U.S.A.
Ara Aprahamian$535.6K
Executive Officer
Compensation as of Fiscal Year 2016. All Compensation is in USD.

Average Compensation in the Pharmaceuticals Industry

Pharmaceuticals
$577.9K
Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.